Clinical Trials Browser

Giant Cell Tumor of Bone

Sarcoma, Osteosarcoma

Carcinoma, Hepatocellular

Breast Neoplasms

Breast Neoplasms

Carcinoma, Renal Cell

Osteoporosis, Prostatic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Neoplasm Metastasis, Sarcoma, Ewing

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

Prostatic Neoplasms

Lung Neoplasms

Breast Neoplasms, Osteoporosis

Breast Neoplasms, Osteoporosis

Breast Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Multiple Myeloma, Hematologic Neoplasms

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Multiple Myeloma, Neoplasms, Plasma Cell

Prostatic Neoplasms

Breast Neoplasms

Clinical Trials

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

OS2006

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

HOBOE

Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole

MOSCAR

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

EWING2008

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

ZAPCA

NATAN

CTIBL

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole